2021
Association between percentage of positive biopsy cores and risk of pelvic lymph node involvement in prostate cancer.
Yang D, Dee E, Arega M, Nguyen P, Orio P, King M, Kann B, Yu J, Cook K, Ma T, Kishan A, Muralidhar V. Association between percentage of positive biopsy cores and risk of pelvic lymph node involvement in prostate cancer. Journal Of Clinical Oncology 2021, 39: 205-205. DOI: 10.1200/jco.2021.39.6_suppl.205.Peer-Reviewed Original ResearchPercentage of positive biopsy coresRisk of pelvic lymph node involvementPelvic lymph node involvementLymph node involvementPositive biopsy coresPelvic lymph nodesProstate cancerRadical prostatectomyBiopsy coresNode involvementLymph nodesDefinitive treatment of prostate cancerGleason 9-10 diseasePositive pelvic lymph nodesTreatment of prostate cancerBiopsy Gleason scoreClinicopathological prognostic variablesElective nodal irradiationGleason 8 diseasePathologic nodal evaluationClinical tumor stageNational Cancer DatabaseTime of RPClinically relevant associationMultivariate logistic regression
2019
Moderate hypofractionation and stereotactic body radiation therapy in the treatment of prostate cancer
Beckta J, Nosrati J, Yu J. Moderate hypofractionation and stereotactic body radiation therapy in the treatment of prostate cancer. Urologic Oncology Seminars And Original Investigations 2019, 37: 619-627. PMID: 30738746, DOI: 10.1016/j.urolonc.2019.01.015.Peer-Reviewed Original ResearchConceptsModerate hypofractionationRadiation therapyStereotactic body radiation therapyProstate cancer radiation therapyTreatment of prostate cancerCancer radiation therapyReduced duration of treatmentDuration of treatmentStandard of careCurative intentProstate cancerHigh dosesHypofractionationReduced durationDaily sessionsFractionation schemeTherapyEffective alternativeTreatmentProstatePatientsCancerDoseMonthsCare
2016
Emerging Technologies and Techniques in Radiation Therapy
Magnuson W, Mahal A, Yu J. Emerging Technologies and Techniques in Radiation Therapy. Seminars In Radiation Oncology 2016, 27: 34-42. PMID: 27986210, DOI: 10.1016/j.semradonc.2016.08.004.Peer-Reviewed Original ResearchConceptsStereotactic body radiotherapyHigh-dose-rateProton beam radiationRadiation therapyProstate cancerHigh-dose-rate (HDR) brachytherapyHigh-risk prostate cancer patientsHigh-risk prostate cancerTreatment of prostate cancerPartial gland treatmentProstate-directed therapyRegional radiation therapyLow-risk diseaseBeam radiationProstate cancer patientsDeliver radiationImprove cancer controlHigh-intensity focused ultrasoundFocal therapyTherapeutic modalitiesRadiation treatmentCancer patientsCancer controlTherapyReduced toxicity